Last reviewed · How we verify
NCT03392857: EOLE
End Of Life in the Critically Ill patiEnt
trial testing Assessment by caregivers of the quality of the end of life in intensive care units in Terminal Illness in 514 participants. Completed in 13 February 2019.
16 October 2018
Quick facts
| Lead sponsor | French Society for Intensive Care |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 514 |
| Start date | 28 March 2018 |
| Primary completion | 16 October 2018 |
| Estimated completion | 13 February 2019 |
| Sites | 112 locations across France |
Drugs / interventions tested
- Assessment by caregivers of the quality of the end of life in intensive care units
Conditions studied
- Terminal Illness — all drugs for Terminal Illness →
- Intensive Care Unit Syndrome — all drugs for Intensive Care Unit Syndrome →
Sponsor
French Society for Intensive Care
Who can join
18 and older, any sex, with Terminal Illness or Intensive Care Unit Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this multicentric study is to evaluate the perception of the quality of the end of life in intensive care units seen from the side of the caregivers, trough the CAESAR scale.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
End of life in the critically ill patient: evaluation of experience of end of life by caregivers (EOLE study).
SRLF Trial Group. · · 2021 · cited 5× · PMID 34825996 · DOI 10.1186/s13613-021-00944-z
Verify or expand the search:
- PubMed search for NCT03392857
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Terminal Illness
Currently open trials in the same condition.
- NCT04612738 — Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations · NA · recruiting
- NCT04257227 — Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness · NA · recruiting
Other French Society for Intensive Care trials
Trials by the same sponsor.
- NCT06243094 — Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA) · unknown
- NCT07176247 — Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidru · enrolling by invitation
- NCT06455696 — Intra-Hospital Transport of Critically Ill Patients in Intensive Care Unit · recruiting
- NCT05775770 — Blood Glucose Management in Intensive Care Units · unknown
- NCT04304339 — Hypercapnic Acute Respiratory Failure in the ICU : the YETI Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03392857 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by French Society for Intensive Care
- Last refreshed: 15 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03392857.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing